0.9889
price down icon3.99%   -0.0411
after-market アフターアワーズ: .98 -0.0089 -0.90%
loading
前日終値:
$1.03
開ける:
$0.9957
24時間の取引高:
157.96K
Relative Volume:
1.89
時価総額:
$4.29M
収益:
$79,300
当期純損益:
$-6.92M
株価収益率:
-0.0521
EPS:
-18.9818
ネットキャッシュフロー:
$-5.34M
1週間 パフォーマンス:
+2.95%
1か月 パフォーマンス:
+30.12%
6か月 パフォーマンス:
-53.57%
1年 パフォーマンス:
-15.48%
1日の値動き範囲:
Value
$0.97
$1.03
1週間の範囲:
Value
$0.97
$1.14
52週間の値動き範囲:
Value
$0.7387
$8.9999

Virax Biolabs Group Ltd Stock (VRAX) Company Profile

Name
名前
Virax Biolabs Group Ltd
Name
セクター
Healthcare (1164)
Name
電話
-
Name
住所
-
Name
職員
19
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
VRAX's Discussions on Twitter

VRAX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VRAX
Virax Biolabs Group Ltd
0.9889 4.47M 79,300 -6.92M -5.34M -18.98
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-31 開始されました H.C. Wainwright Buy

Virax Biolabs Group Ltd (VRAX) 最新ニュース

pulisher
09:36 AM

Technical Analysis: TGB Banquets and Hotels Limited (532845)Consistent wealth multiplication - Autocar Professional

09:36 AM
pulisher
Jul 23, 2025

Virax Biolabs Group Limited Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Technical Analysis: SPEL Semiconductor Limited (517166)Extraordinary performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Virax Biolabs Group Limited a good long term investmentSuperior trading gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Allient Inc. stockGame-changing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

AI for Trademark Infringement DetectionAlpha Stock Ideas - Newser

Jul 21, 2025
pulisher
Jul 20, 2025

ICICI Prudential AMC Ltd (542631) Announces Strategic ShiftExceptional earning trajectories - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Virax Biolabs Group Limited stock priceAccelerated wealth building - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Virax Biolabs receives Nasdaq minimum bid price deficiency notice - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Virax Biolabs receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Virax Biolabs Gets NASDAQ Deficiency Notice: What the 180-Day Compliance Timeline Means for Investors - Stock Titan

Jul 18, 2025
pulisher
Jul 15, 2025

How Virax Biolabs Group Limited stock performs during market volatilityFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ATCH stock attracts strong analyst attentionFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Virax Biolabs Group Limited stock attracts strong analyst attentionFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Virax Biolabs Group Limited stock price move sharplyHigh Probability Setups - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 0.7% – Time to Buy? - Defense World

Jul 09, 2025
pulisher
Jul 04, 2025

Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations - simplywall.st

Jul 04, 2025
pulisher
Jun 13, 2025

Virax Biolabs Announces CFO Resignation and Transition - TipRanks

Jun 13, 2025
pulisher
Jun 10, 2025

FibroBiologics names new CFO after going public last year - The Business Journals

Jun 10, 2025
pulisher
May 24, 2025

Kaival Brands Innovations Group (NASDAQ:KAVL) Trading Down 1.2% – Time to Sell? - Defense World

May 24, 2025
pulisher
May 24, 2025

Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 2% – Here’s What Happened - Defense World

May 24, 2025
pulisher
Apr 25, 2025

Virax Biolabs Group (NASDAQ:VRAX) Trading Up 6.9% – Here’s What Happened - Defense World

Apr 25, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 04, 2025

FY2025 Earnings Estimate for VRAX Issued By HC Wainwright - Defense World

Apr 04, 2025
pulisher
Apr 01, 2025

Virax Biolabs Group (NASDAQ:VRAX) Coverage Initiated by Analysts at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Virax Biolabs Group Ltd.’s Innovative Diagnostics and Strategic Collaborations Justify Buy Rating - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

ELISpot and FluoroSpot Assay Market Size to Hit USD 576.59 Million by 2034 - Precedence Research

Mar 28, 2025
pulisher
Mar 22, 2025

Virax Biolabs Group (NASDAQ:VRAX) Stock Price Down 3.9% – What’s Next? - Defense World

Mar 22, 2025
pulisher
Mar 18, 2025

Virax Biolabs Launches Clinical Study on T Cell Dysfunction - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Virax Biolabs begins UK clinical study on T cell dysfunction - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Breakthrough T Cell Study: Virax Targets Long COVID and Chronic Fatigue Diagnosis Revolution - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Virax Biolabs Highlights T-Cell Dysfunction in Post-Infection Syndromes - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Virax Biolabs shares T-Cell dysfunction findings - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Virax Biolabs shares T-Cell dysfunction findings By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Game-Changing Long COVID Diagnostic: Virax's New T-Cell Test Shows Promising Results - StockTitan

Mar 13, 2025
pulisher
Mar 05, 2025

Virax Biolabs to Present at World Immune Regulation Meeting - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Can Virax's T-Cell Research at WIRM 2025 Advance Post-Infection Syndrome Treatment? - StockTitan

Mar 05, 2025
pulisher
Mar 01, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Up 205.8% in February - The AM Reporter

Mar 01, 2025
pulisher
Feb 28, 2025

Cosmos Health expands distribution of Avian Influenza kits - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Expands By 205.8% - Defense World

Feb 28, 2025
pulisher
Feb 25, 2025

Virax Biolabs aligns with US vaccine transparency efforts By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Virax Biolabs Aligns with US Health Department on Vaccine Transparency - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

How Virax's Vaccine Testing Tech Could Capitalize on New Government Transparency Push - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency - Benzinga

Feb 25, 2025
pulisher
Feb 20, 2025

Contrasting Virax Biolabs Group (NASDAQ:VRAX) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Feb 20, 2025
pulisher
Feb 10, 2025

Market Watch: Virax Biolabs Group Ltd (VRAX)’s Noteworthy Drop, Closing at 1.71 - The Dwinnex

Feb 10, 2025
pulisher
Feb 02, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 33.9% in January - Armenian Reporter

Feb 02, 2025

Virax Biolabs Group Ltd (VRAX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):